Default company panoramic image


Early-stage drug development company developing a game-changing, neuroprotective and remyelinating drug for the treatment of MS and orphan diseases ON and NMO.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Barcelona, Spain
  • Currency USD
  • Founded 2009
  • Employees 7
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.